Peripheral arterial disease and chronic heart failure: A dangerous mix

Heart Failure Reviews

Volumn 18, Issue 4, 2013, Pages 457-464

  Inglis, Sally C ^a   Hermis, Adriana ^a   Shehab, Sajad ^a   Newton, Phillip J ^a   Lal, Sara ^a   Davidson, Patricia M ^a  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

Chronic heart failure; Function; Mortality; Outcomes; Peripheral arterial disease; Prevalence

Indexed keywords

BUCINDOLOL; PLACEBO; ROSUVASTATIN;

ADULT; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; EXERCISE; FEMALE; HEALTH BEHAVIOR; HEART FAILURE; HUMAN; INTERMITTENT CLAUDICATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; PREVALENCE; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SELF CARE; SMOKING; SYSTEMATIC REVIEW;

CHRONIC DISEASE; HEART FAILURE; HOSPITALIZATION; HUMANS; PERIPHERAL ARTERIAL DISEASE; PREVALENCE; PROGNOSIS; RISK FACTORS; UNITED STATES;

EID: 84879069911     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-012-9331-1     Document Type: Review

References (49)

1. Jones WS, Clare R, Ellis SJ, Mills JS, Fischman DL, Kraus WE et al (2011) Effect of peripheral arterial disease on functional and clinical outcomes in patients with heart failure (from HF-ACTION). Am J Cardiol 108:380-384
2. Inglis SC, McMurray JV, Böhm M, Schaufelberger M, Dirk J, Lindberg M et al (2010) Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the controlled rosuvastatin multinational trial in heart failure trial (CORONA). Eur J Heart Fail 12:698-705
3. Ahmed MI, Aronow WS, Criqui MH, Aban I, Love TE, Eichhorn EJ et al (2010) Effects of peripheral arterial disease on outcomes in advanced chronic systolic heart failure. Circ Heart Fail 3:118-124
4. Hebert K, Lopez B, Michael C, Franco E, Dias A, Trahan P et al (2009) The prevalence of peripheral arterial disease in patients with heart failure by race and ethnicity. Congest Heart Fail 16:118-121
5. Edelmann F, Stahrenberg R, Gelbrich G, Durstewitz K, Angermann C, Düngen H-D et al (2011) Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction. Clin Res Cardiol 100:755-764
6. Selvin E, Erlinger TP (2004) Prevalence of and risk factors for peripheral arterial disease in the United States. Circulation 110:738-743
7. McDermott MM, Guralnik JM, Ferrucci L, Tian L, Liu K, Liao Y et al (2008) Asymptomatic peripheral arterial disease is associated with more adverse lower extremity characteristics than intermittent claudication. Circulation 117:2484-2491
8. Norgren L, Hiatt W, Dormandy J, Nehler M, Harris K, Fowkes F, on behalf of the TASC II Working Group (2007) Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 33:S1-S75
9. Zeymer U, Parhofer KG, Pittrow D, Binz C, Schwertfeger M, Limbourg T et al (2009) Risk factor profile, management and prognosis of patients with peripheral arterial disease with or without coronary artery disease: results of the prospective german reach registry cohort. Clin Res Cardiol 98:249-256
10. Hankey GJ, Norman PE, Eikelboom JW (2006) Medical treatment of peripheral arterial disease. JAMA 295:547-553
11. Lend GC, Fowkes FGR (1992) The Edinburgh Claudication Questionnaire: an improved version of the WHO/ROSE questionnaire for use in epidemiological surveys. J Clin Epidemiol 45:1101-1109
12. Grenon SM, Gagnon J, Hsiang Y (2009) Ankle-brachial index for assessment of peripheral arterial disease. New Engl J Med 361:e40
13. Ankle Brachial Index Collaboration (2008) Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: a meta-analysis. JAMA 300:197-208
14. Baena-Díez JM, Alzamora MT, Forés R, Pera G, Torán P, Sorribes M (2011) Ankle-brachial index improves the classification of cardiovascular risk: PERART/ARTPER study. Rev Esp Cardiol 64:186-192
15. Criqui MH, Ninomiya JK, Wingard DL, Ji M, Fronek A (2008) Progression of peripheral arterial disease predicts cardiovascular disease morbidity and mortality. J Am Coll Cardiol 52:1736-1742
16. Hirsch AT (2001) Peripheral arterial disease detection, awareness and treatment in primary care. JAMA 286:1317-1324
17. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL et al (2006) ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American association for vascular surgery/society for vascular surgery, Society for cardiovascular angiography and interventions, Society for vascular medicine and biology, Society of interventional radiology, and the ACC/AHA task force on practice guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease): endorsed by the American association of cardiovascular and pulmonary rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; Transatlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol 47:1239-1312
18. Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss LK et al (2011) 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 58:2020-2045
19. Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clément D, Collet J-P et al (2011) ESC guidelines on the diagnosis and treatment of peripheral artery diseases. Eur Heart J 32:2851-2906
20. Xu DC, Li J, Zou LL, Xu YW, Hu DY, Pagoto SL et al (2010) Sensitivity and specificity of the ankle-brachial index to diagnose peripheral artery disease: a structured review. Vasc Med. 15:361-369
21. Khan TH, Faroqui FA, Niazi K (2008) Critical review of the ankle brachial index. Curr Cardiol Rev 4:101-106
22. Coutinho T, Rooke TW, Kullo IJ (2011) Arterial dysfunction and functional performance in patients with peripheral artery disease: a review. Vasc Med 16:203-211
23. Stewart AL, Greenfield S, Hays RD, Wells K, Rogers WH, Berry SD et al (1989) Functional status and well-being of patients with chronic conditions. JAMA 262:907-913
24. Tierney S, Mamas M, Skelton D, Woods S, Rutter MK, Gibson M et al (2011) What can we learn from patients with heart failure about exercise adherence? A systematic review of qualitative papers. Health Psychol 30:401-410
25. Hebert PL, Sisk JE (2008) Challenges facing nurse-led disease management for heart failure. Dis Manage Health Outcomes 16:1
26. McDermott MM, Ades P, Guralnik JM, Dyer A, Ferrucci L, Liu K et al (2009) Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication. JAMA 301:165-174
27. Anand RG, Ventura HO, Mehra MR (2007) Is heart failure more prevalent in patients with peripheral arterial disease? A meta-analysis. Congest Heart Fail. 13:319-322
28. The Beta-Blocker Evaluation of Survival Trial Investigators (2001) A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. New Engl J Med 344:1659-1667
29. Kjekshus J, Dunselman P, Blideskog M, Eskilson C, Hjalmarson K, McMurray JV et al (2005) A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics. Eur J Heart Fail 7:1059-1069
30. Kjekshus J, Apetrei E, Barrios V, Bohm M, Cleland JGF, Cornel JH et al (2007) Rosuvastatin in older patients with systolic heart failure. New Engl J Med 357:2248-2261
31. O'Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ et al (2009) Efficacy and safety of exercise training in patients with chronic heart failure. JAMA 301:1439-1450
32. Ostchega Y, Paulose-Ram R, Dillon CF, Gu Q, Hughes JP (2007) Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: data from the national health and nutrition examination survey 1999-2004. J Am Geriatr Soc 55:583-589
33. Hirsch AT, Gotto AM Jr (2002) Undertreatment of dyslipidemia in peripheral arterial disease and other high-risk populations: an opportunity for cardiovascular disease reduction. Vasc Med 7:323-331
34. Price JF, Mowbray PI, Lee AJ, Rumley A, Lowe GDO, Fowkes FGR (1999) Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease; Edinburgh Artery Study. Eur Heart J 20:344-353
35. Diehm C, Allenberg JR, Pittrow D, Mahn M, Tepohl G, Haberl RL et al (2009) Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation 120:2053-2061
36. Aponte J (2011) The prevalence of asymptomatic and symptomatic peripheral arterial disease and peripheral arterial disease risk factors in the US population. Holist Nurs Pract 25:147-161
37. Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ (1991) Edinburgh artery study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 20:384-392
38. McAlister FA, Stewart S, Ferrua S, McMurray JJ (2004) Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. J Am Coll Cardiol 44:810-819
39. Inglis SC, Clark RA, McAlister FA, Stewart S, Cleland JGF (2011) Which components of heart failure programmes are effective? A systematic review and meta-analysis of the outcomes of structured telephone support or telemonitoring as the primary component of chronic heart failure management in 8323 patients: abridged cochrane review. Eur J Heart Fail 13:1028-1040
40. Murad K, Kitzman D (2012) Frailty and multiple comorbidities in the elderly patient with heart failure: Implications for management. Heart Fail Rev 17:581-588
41. Heiat A, Gross CP, Krumholz HM (2002) Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med 162:1682-1688
42. Kitzman DW, Rich MW (2010) Age disparities in heart failure research. JAMA 304:1950-1951
43. Aronow WS (2009) Peripheral arterial disease in women. Maturitas 64:204-211
44. Vavra AK, Kibbe MR (2009) Women and peripheral arterial disease. Women's Health 5:669-683
45. McDermott MM, Ferrucci L, Liu K, Guralnik JM, Tian L, Kibbe M et al (2011) Women with peripheral arterial disease experience faster functional decline than men with peripheral arterial disease. J Am Coll Cardiol 57:707-714
46. Criqui MH, Fronek A, Barrett-Connor E, Klauber MR, Gabriel S, Goodman D (1985) The prevalence of peripheral arterial disease in a defined population. Circulation 71:510-515
47. Bendermacher BLW, Teijink JAW, Willigendael EM, Bartelink ML, Buller HR, Peters RJG et al (2006) Symptomatic peripheral arterial disease: the value of a validated questionnaire and a clinical decision rule. Br Gen Pract 56:932-937
48. Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE et al (2008) Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: a meta-analysis. JAMA 300:197-208
49. Stoffers HE, Kester AD, Kaiser V, Rinkens PE, Kitslaar PJ, Knottnerus JA (1996) The diagnostic value of the measurement of the ankle-brachial systolic pressure index in primary health care. J Clin Epidemiol 49:1401-1405